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Three-dimensional (3D) printing has emerged as a promising modality for the production of
medical devices. Here we describe the design, production, and implementation of a series of sizing
tools for use in an intraoperative breast brachytherapy program. These devices were produced
using a commercially available low-cost 3D printer and software, and their implementation resulted
in an immediate decrease in consumable costs without affecting the quality of care or the speed of
delivery. This work illustrates the potential of 3D printing to revolutionize the ﬁeld of medical
devices, enabling physicians to rapidly develop and prototype novel tools.
Copyright ª 2016 the Authors. Published by Elsevier Inc. on behalf of the American Society for
Radiation Oncology. This is an open access article under the CC BY-NC-ND license (http://
creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
More than 234,000 new cases of breast carcinoma are
expected in the United States in 2015, composing 29% of
all new cancer diagnoses in women this year.1 Two-
thirds of these cases are localized disease at diagnosis.
Practice patterns reveal nearly 60% of patients with
early-stage breast cancer (stage I or II) receive breast-Conﬂicts of interest: None.
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article under the CC BY-NC-ND license (http://creativecommons.org/licenses/conserving therapy and should be evaluated for radia-
tion therapy as part of their management.2 The standard
of care in whole-breast external beam radiation therapy
has been to deliver 45 to 50 Gy with or without a 10 to 16
Gy boost over 5 to 6 weeks of treatment. However, this
standard fractionation scheme can be burdensome for
patients living in remote areas who may have to travel
long distances to receive care. It is also less popular in
closed systems, such as the Canadian and British health
care systems, in which there are fewer facilities and
greater pressure to control cost of care. The end result has
been the development of both hypofractionated whole-
breast radiation therapy and accelerated partial breast
irradiation regimens, which are able to shorten treatmentof the American Society for Radiation Oncology. This is an open access
by-nc-nd/4.0/).
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most hypofractionation regimens to a single treatment in
the case of intraoperative radiation therapy (IORT).3,4
There are a range of techniques currently in use to
deliver accelerated partial breast irradiation, including
external beam radiation therapy, interstitial brachyther-
apy, balloon brachytherapy, and IORT.
Intraoperative electronic brachytherapy has been used
to deliver adjuvant IORT to 116 patients at our insti-
tution since December 2009. All treatments have been
delivered using a Zeiss Intrabeam device, which gener-
ates 50 kV photons at the center of a spherical appli-
cator. Applicator sizes range from 1.5 cm to 5 cm
sphere diameter in 0.5 cm increments. The surface of the
resection cavity receives 20 Gy over 20 to 35 minutes
and the dose is attenuated to 5 to 7 Gy at a depth of 1
cm from the surface of the applicator. Patients eligible
for IORT at our institution are based on the American
Society for Radiation Oncology consensus guidelines:
age 60 years, size 2 cm, pN0 by sentinel node bi-
opsy or axillary dissection, estrogen receptor positive,
resection margin negative by 2 mm, and unifocal
disease.3 This technique has proven invaluable in the
treatment of well-selected patients, some of whom
would have otherwise decided to forgo breast conser-
vation or adjuvant radiation therapy because of
geographic or personal constraints. We have experienced
good results with regard to cosmesis and toxicity,
experiencing a single incidence of skin necrosis during
our 6 year experience. The Targeted Intraoperative
Radiotherapy versus Whole Breast Radiotherapy for
Breast Cancer trial revealed similar rates of local control
when comparing standard fractionation whole-breast
radiation therapy with IORT.5,6
Optimal use of the electronic brachytherapy system is
dependent on selection of an appropriately sized appli-
cator for each patient. Sizing of the applicators intra-
operatively typically consists of serially testing multiple
applicator diameters until one is identiﬁed that ﬁlls the
surgical defect as precisely as possible. This cavity sizing
is typically performed using functional brachytherapy
applicators. However, our institutional experience
revealed that a major cost associated with the program is
the brachytherapy applicators themselves. There are 8
available applicator sizes, with a retail cost of $10,300 per
applicator, and the individual devices have a useable
lifespan of 100 sterilization cycles. One simple solution to
minimize cost implemented early in our program was to
sterilize each applicator individually. This enabled sur-
geons to request speciﬁc sizes of brachytherapy applicator
to assess best cavity ﬁt, without subjecting the entire set to
a sterilization cycle unnecessarily. During 116 cases at
our institution, there have been 529 sterilization cycles
performed on individual applicators, averaging 4.6 ster-
ilization cycles per IORT case. Based on the replacement
cost of the IORT applicators, an average of $371 perprocedure was wasted on IORT applicators used for
sizing purposes alone. Over the past 6 years of our pro-
gram, this has resulted in more than $43,000 worth of the
useful life of IORT applicators being used on lumpectomy
cavity sizing only and not to deliver radiation therapy.
There has been a proliferation of low-cost commer-
cially available 3-dimensional (3D) printing systems.
There are now many examples of 3D printing technology
being used for medical modeling, devices, and, more
recently, implants.7-9 This technology has ushered in a
new era in which it is possible to perform rapid proto-
typing and development of new medical devices, in many
cases without having to undergo lengthy and costly
development processes that previously hindered innova-
tion. The most ubiquitous and lowest cost technology
currently available is fused deposition modeling (FDM)
printing, a process in which thermoplastic material is
simultaneously heated and extruded through a nozzle onto
a print bed, building the model in successive layers.10 The
quality of the ﬁnished product is dependent on the layer
height and extruder nozzle diameter, which typically
ranges between 20 and 200 m for commercially available
FDM printers.Methods and results
At Oregon Health & Science University, two breast-
conserving therapy patients have been successfully treated
with intra-operative radiation therapy after using 3D
printed thermoplastic tools to determine lumpectomy
cavity size. These tools were designed with dimensions
identical to functional IORT applicators, allowing us to
eliminate the need to use functional brachytherapy ap-
plicators for sizing purposes alone. We used computer
aided design software (Autocad 2015, Autodesk, San
Rafael, CA) to design sizing tools with sphere sizes
identical to functional IORT applicators (Fig 1A). A low-
cost FDM printer (Ultimaker 2, Ultimaker, Geldermalsen,
Netherlands) was then used to make the sizing tools out of
polylactic acid thermoplastic material (Fig 1B). To ensure
accurate replication of functional IORT applicators, some
postprocessing of the sizing tools is required to remove
support structures needed during printing and sanding to
remove minor surface imperfections. Sizing tools used in
this publication were printed using a layer height of 40 m,
and ﬁnal dimensions of the devices were within 0.3 mm,
or a maximum of 2%, of the functional applicator and
planned computer aided design dimensions.
The brachytherapy sizing tools used in this study were
manufactured in fewer than 5 days using less than $20 in
consumable materials. The total cost of manufacturing a
complete set of sizing tools, inclusive of 3D printer
purchase, material costs, and labor, is less than $2500.
This was compared with traditional manufacturing
methods, and 3D printing the sizing tools was found to be
Figure 1 Illustration of the computer-aided design ﬁle for a 2.5 cm sizing tool (A); intraoperative radiation therapy sizing tools being
printed with support structures in place that are removed during postprocessing (B); a 2.5 cm sizing tool being used intraoperatively (C).
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specialty surgical tool manufacturers. Based on the pre-
viously discussed savings estimates of $371 per proce-
dure after introduction of the sizing tools, we estimate
that our per-procedure savings will exceed the amount
spent to manufacture the tools after as few as 7 brachy-
therapy procedures. Others performing cost analysis have
demonstrated that functional sterile surgical tools are able
to be produced using 3D printing at one-tenth the cost of
traditional manufacturing techniques.11 Three-
dimensional printing is considered by many to be a
“slow” manufacturing technique because of the time
required to produce individual parts using additive
manufacturing; however, by 3D printing the sizing tools
used in this publication we were able to obtain them in a
fraction of the time required to obtain custom milled part
from traditional manufacturers.
The polylactic acid material used to produce the
sizing tools in this publication is not approved for high
temperature sterilization or for direct contact with pa-
tient tissue. To implement their use in the operating
room, the 3D printed sizing tools were sheathed in
sterile disposable plastic bags similar to what is used
for ultrasound probes intraoperatively (Fig 1C),
allowing for reuse of the devices. Before their use, a
surgical nurse can prepare a full set of sizing tools in
this manner, allowing the surgeon to test multiple
applicator sizes quickly before selecting an appropriate
one and requesting a functional IORT applicator of the
same dimensions. This technique has allowed our
IORT team to eliminate the use of functional applica-
tors for sizing purposes and eliminate the wasted
sterilization cycles previously required to determine
resection cavity size. Both patients treated thus far
using these 3D printed sizing tools have then gone on
to receive IORT without having to use more than a
single IORT applicator during the procedure, and use
of the devices did not add signiﬁcant time to the
procedure. The change in the dimensions of the sizing
tool after placing it in a sterile bag for use in the
sterile ﬁeld did not pose a signiﬁcant hindrance, andthe operating surgeons were satisﬁed with the manner
in which the tools approximated lumpectomy cavity
size before proceeding with IORT.
Discussion
This work demonstrates that a low-cost, commer-
cially available, 3D printer can now be used to design
and produce functional tools capable of being incorpo-
rated into surgical and radiation therapy practice in a
matter of weeks. The tools produced in this study are
now saving our IORT program more than $300 per
breast brachytherapy procedure in consumable costs.
For larger IORT programs, this could amount to tens of
thousands of dollars per year in savings. We are now
experimenting with additional materials, such as nylon,
which will ultimately allow for high-temperature steril-
ization of these tools in the future, further streamlining
their use. As 3D printing becomes more pervasive and
additional materials become available that are specif-
ically designed for clinical use, we anticipate this tech-
nology will remove many barriers that previously
existed to physicians developing and implementing tools
for use in their own practice. This technology will also
enable clinicians and researchers to develop publicly
available databases of tools that can be produced and
modiﬁed by others. In this spirit, the devices described
in this publication have been made available at this
URL: www.shapeways.com/shops/radmed.Acknowledgments
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